Comparison of carboplatin–paclitaxel to docetaxel–cisplatin-5–flurouracil induction chemotherapy followed by concurrent chemoradiation for locally advanced head and neck cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Oral Surgery
Reference32 articles.
1. Head and neck carcinoma in the United States: first comprehensive report of the Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN);Ang;Cancer.,2012
2. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med. 1991; 324(24): 1685–90.
3. Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial;Lorch;Lancet Oncol,2011
4. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer;Vermorken;N Engl J Med,2007
5. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer;Posner;N Engl J Med,2007
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Induction chemotherapy in locally advanced head and neck cancers, is there a best choice?;Critical Reviews in Oncology/Hematology;2023-06
2. Response to induction chemotherapy predicts survival outcomes in oropharyngeal cancer;Cancer Medicine;2023-01-27
3. Combination Therapy Comprising Paclitaxel and 5-Fluorouracil by Using Folic Acid Functionalized Bovine Milk Exosomes Improves the Therapeutic Efficacy against Breast Cancer;Life;2022-07-28
4. Current status of systemic therapy in head and neck cancer;Journal of Chemotherapy;2021-07-24
5. “CLINICALASSESSMENT OF TREATMENT RELATED TOXICITY AND RESPONSE BY CONCOMITANT CHEMORADIATION THERAPY IN LOCALLY ADVANCED HEAD AND NECK CARCINOMA”;INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH;2021-07-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3